{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:13:11Z","timestamp":1788340391259,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00344706"],"award-info":[{"award-number":["RS-2024-00344706"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00458826"],"award-info":[{"award-number":["RS-2024-00458826"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["800-20250268"],"award-info":[{"award-number":["800-20250268"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["800-20250268"],"award-info":[{"award-number":["800-20250268"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Postmenopausal osteoporosis (PMOP) arises from a bone remodeling imbalance in which osteoclast-mediated resorption exceeds osteoblast-driven formation. However, current therapies primarily target osteoclasts without restoring osteoblast function, underscoring the need for mechanism-driven dual-action approaches. Here, we identify neddylation as a post-translational modification that reciprocally regulates osteoclast and osteoblast differentiation. In bone tissue from patients with PMOP, NEDD8 and its activating enzyme NAE1 were significantly upregulated, indicating heightened pathway activity. Mechanistically, c-Cbl neddylates NFATc1 to promote osteoclastogenesis, whereas Rbx1 neddylates Runx2 to suppress osteoblast maturation. Pharmacological blockade with the NAE1 inhibitor MLN4924 counteracted both effects and, in ovariectomized mice, reduced osteoclast activity while preserving osteoblast function, preventing deterioration of bone mass and microarchitecture. In human PMOP bone tissues, elevated NEDD8 and NAE1 expression was associated with increased NFATc1 in osteoclast-lineage cells and reduced Runx2 in osteoblast-lineage cells, suggesting translational relevance. These findings reveal neddylation as a unifying mechanism that coordinates opposing effects on osteoclast and osteoblast master transcription factors and highlight its potential as a mechanism-driven dual-action therapeutic target.<\/jats:p>","DOI":"10.1038\/s12276-026-01784-2","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:09:24Z","timestamp":1785722964000},"page":"2603-2619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neddylation of NFATc1 and Runx2 regulates osteoclast\u2013osteoblast balance and represents a dual-action therapeutic target for postmenopausal osteoporosis"],"prefix":"10.1038","volume":"58","author":[{"given":"Jooseung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-5191","authenticated-orcid":false,"given":"Jong-Wan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Bum","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-121X","authenticated-orcid":false,"given":"Sung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1261-9498","authenticated-orcid":false,"given":"Yang-Sook","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"1784_CR1","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","volume":"2","author":"A-M Wu","year":"2021","unstructured":"Wu, A.-M. et al. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2, e580\u2013e592 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"1784_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"J-Y Reginster","year":"2006","unstructured":"Reginster, J.-Y. & Burlet, N. Osteoporosis: a still increasing prevalence. Bone 38, 4\u20139 (2006).","journal-title":"Bone"},{"key":"1784_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen, T., Ozisik, L. & Basaran, N. C. An overview and management of osteoporosis. Eur. J. Rheumatol. 4, 46\u201356 (2017).","journal-title":"Eur. J. Rheumatol."},{"key":"1784_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake, M. T., Clarke, B. L. & Khosla, S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc. 83, 1032\u20131045 (2008).","journal-title":"Mayo Clin. Proc."},{"key":"1784_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"R Cummings Steven","year":"2009","unstructured":"Cummings Steven, R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756\u2013765 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1784_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41584-025-01287-w","volume":"21","author":"N Fuggle","year":"2025","unstructured":"Fuggle, N. et al. Parathyroid hormone receptor agonists in the management of osteoporosis. Nat. Rev. Rheumatol. 21, 599\u2013611 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1784_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40266-020-00793-8","volume":"37","author":"J Paik","year":"2020","unstructured":"Paik, J. & Scott, L. J. Romosozumab: a review in postmenopausal osteoporosis. Drugs Aging 37, 845\u2013855 (2020).","journal-title":"Drugs Aging"},{"key":"1784_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00223-010-9364-1","volume":"86","author":"B Abrahamsen","year":"2010","unstructured":"Abrahamsen, B. Adverse effects of bisphosphonates. Calcif. Tissue Int. 86, 421\u2013435 (2010).","journal-title":"Calcif. Tissue Int."},{"key":"1784_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M22-1034","volume":"176","author":"A Qaseem","year":"2023","unstructured":"Qaseem, A. et al. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann. Intern. Med. 176, 224\u2013238 (2023).","journal-title":"Ann. Intern. Med."},{"key":"1784_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40520-024-02826-3","volume":"36","author":"N Veronese","year":"2024","unstructured":"Veronese, N. et al. Recommendations for the optimal use of bone forming agents in osteoporosis. Aging Clin. Exp. Res. 36, 167 (2024).","journal-title":"Aging Clin. Exp. Res."},{"key":"1784_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell, R. et al. Postmenopausal osteoporosis. Nat. Rev. Dis. Prim. 2, 16069 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1784_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jbmr.262","volume":"26","author":"S Khosla","year":"2011","unstructured":"Khosla, S., Melton, L. J. III & Riggs, B. L. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed. J. Bone Min. Res. 26, 441\u2013451 (2011).","journal-title":"J. Bone Min. Res."},{"key":"1784_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112814","volume":"408","author":"J Schiavi","year":"2021","unstructured":"Schiavi, J., Fodera, D. M., Brennan, M. A. & McNamara, L. M. Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro. Exp. Cell Res. 408, 112814 (2021).","journal-title":"Exp. Cell Res."},{"key":"1784_CR14","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302665R","volume":"38","author":"Y Zhong","year":"2024","unstructured":"Zhong, Y., Zhou, X., Pan, Z., Zhang, J. & Pan, J. Role of epigenetic regulatory mechanisms in age-related bone homeostasis imbalance. FASEB J. 38, e23642 (2024).","journal-title":"FASEB J."},{"key":"1784_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nm.4076","volume":"22","author":"J Luo","year":"2016","unstructured":"Luo, J. et al. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat. Med. 22, 539\u2013546 (2016).","journal-title":"Nat. Med."},{"key":"1784_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3389\/fimmu.2020.00937","volume":"11","author":"D Rolph","year":"2020","unstructured":"Rolph, D. & Das, H. Transcriptional regulation of osteoclastogenesis: the emerging role of KLF2. Front. Immunol. 11, 937 (2020).","journal-title":"Front. Immunol."},{"key":"1784_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim, J. H. & Kim, N. Regulation of NFATc1 in osteoclast differentiation. J. Bone Metab. 21, 233\u2013241 (2014).","journal-title":"J. Bone Metab."},{"key":"1784_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117389","volume":"245","author":"K Gomathi","year":"2020","unstructured":"Gomathi, K., Akshaya, N., Srinaath, N., Moorthi, A. & Selvamurugan, N. Regulation of Runx2 by post-translational modifications in osteoblast differentiation. Life Sci. 245, 117389 (2020).","journal-title":"Life Sci."},{"key":"1784_CR19","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1101\/gad.12.15.2263","volume":"12","author":"F Osaka","year":"1998","unstructured":"Osaka, F. et al. A new NEDD8-ligating system for cullin-4A. Genes Dev. 12, 2263\u20132268 (1998).","journal-title":"Genes Dev."},{"key":"1784_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baab012","volume":"2021","author":"S Ramazi","year":"2021","unstructured":"Ramazi, S. & Zahiri, J. Post-translational modifications in proteins: resources, tools and prediction methods. Database 2021, baab012 (2021).","journal-title":"Database"},{"key":"1784_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/cdd.2016.6","volume":"23","author":"HS Park","year":"2016","unstructured":"Park, H. S. et al. PPAR\u03b3 neddylation essential for adipogenesis is a potential target for treating obesity. Cell Death Differ. 23, 1296\u20131311 (2016).","journal-title":"Cell Death Differ."},{"key":"1784_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1073\/pnas.1213819110","volume":"110","author":"HS Jin","year":"2013","unstructured":"Jin, H. S., Liao, L., Park, Y. & Liu, Y. C. Neddylation pathway regulates T-cell function by targeting an adaptor protein Shc and a protein kinase Erk signaling. Proc. Natl. Acad. Sci. USA 110, 624\u2013629 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1784_CR23","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.3390\/ijms22179509","volume":"22","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Su, H. & Chen, W. Neddylation regulates class IIa and III histone deacetylases to mediate myoblast differentiation. Int J. Mol. Sci. 22, 9509 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"1784_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou, L., Jiang, Y., Luo, Q., Li, L. & Jia, L. Neddylation: a novel modulator of the tumor microenvironment. Mol. Cancer 18, 77 (2019).","journal-title":"Mol. Cancer"},{"key":"1784_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.890121","volume":"10","author":"J Zhu","year":"2022","unstructured":"Zhu, J., Chu, F., Zhang, M., Sun, W. & Zhou, F. Association between neddylation and immune response. Front. Cell Dev. Biol. 10, 890121 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1784_CR26","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s12276-024-01358-0","volume":"56","author":"JB Park","year":"2024","unstructured":"Park, J. B. et al. Neddylation steers the fate of cellular receptors. Exp. Mol. Med. 56, 2569\u20132577 (2024).","journal-title":"Exp. Mol. Med."},{"key":"1784_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01337-w","volume":"9","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell Death Discov. 9, 23 (2023).","journal-title":"Cell Death Discov."},{"key":"1784_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Yu, Q., Li, Z., Zhao, Y. & Sun, Y. Protein neddylation and its role in health and diseases. Signal Transduct. Target. Ther. 9, 85 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1784_CR29","doi-asserted-by":"publisher","first-page":"35209","DOI":"10.1074\/jbc.M505815200","volume":"280","author":"K Kim","year":"2005","unstructured":"Kim, K. et al. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280, 35209\u201335216 (2005).","journal-title":"J. Biol. Chem."},{"key":"1784_CR30","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1074\/jbc.M109.042812","volume":"285","author":"JH Kim","year":"2010","unstructured":"Kim, J. H. et al. Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J. Biol. Chem. 285, 5224\u20135231 (2010).","journal-title":"J. Biol. Chem."},{"key":"1784_CR31","doi-asserted-by":"publisher","first-page":"12994","DOI":"10.1074\/jbc.M111.323105","volume":"287","author":"M-Y Youn","year":"2012","unstructured":"Youn, M.-Y. et al. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation*. J. Biol. Chem. 287, 12994\u201313004 (2012).","journal-title":"J. Biol. Chem."},{"key":"1784_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40240-2","volume":"9","author":"S Narahara","year":"2019","unstructured":"Narahara, S. et al. KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1. Sci. Rep. 9, 3523 (2019).","journal-title":"Sci. Rep."},{"key":"1784_CR33","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41556-023-01229-2","volume":"25","author":"RT Timms","year":"2023","unstructured":"Timms, R. T. et al. Defining E3 ligase\u2013substrate relationships through multiplex CRISPR screening. Nat. Cell Biol. 25, 1535\u20131545 (2023).","journal-title":"Nat. Cell Biol."},{"key":"1784_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.152.1.181","volume":"152","author":"A Sanjay","year":"2001","unstructured":"Sanjay, A. et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181\u2013195 (2001).","journal-title":"J. Cell Biol."},{"key":"1784_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0012-1606(03)00299-9","volume":"261","author":"R Chiusaroli","year":"2003","unstructured":"Chiusaroli, R. et al. Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev. Biol. 261, 537\u2013547 (2003).","journal-title":"Dev. Biol."},{"key":"1784_CR36","doi-asserted-by":"publisher","first-page":"28875","DOI":"10.1074\/jbc.274.41.28875","volume":"274","author":"Y Tintut","year":"1999","unstructured":"Tintut, Y., Parhami, F., Le, V., Karsenty, G. & Demer, L. L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin\/proteasome-dependent regulation. J. Biol. Chem. 274, 28875\u201328879 (1999).","journal-title":"J. Biol. Chem."},{"key":"1784_CR37","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.1074\/jbc.M116.772277","volume":"292","author":"W Zhu","year":"2017","unstructured":"Zhu, W. et al. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation. J. Biol. Chem. 292, 11178\u201311188 (2017).","journal-title":"J. Biol. Chem."},{"key":"1784_CR38","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s11999-011-1909-8","volume":"469","author":"RR Recker","year":"2011","unstructured":"Recker, R. R. & Armas, L. The effect of antiresorptives on bone quality. Clin. Orthop. Relat. Res. 469, 2207\u20132214 (2011).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"1784_CR39","doi-asserted-by":"publisher","unstructured":"Fan, X. et al. Role of ubiquitination in the occurrence and development of osteoporosis (review). Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2024.5392 (2024).","DOI":"10.3892\/ijmm.2024.5392"},{"key":"1784_CR40","doi-asserted-by":"publisher","unstructured":"Liu, H. et al. SUMOylation in skeletal development, homeostasis, and disease. Cells https:\/\/doi.org\/10.3390\/cells11172710 (2022).","DOI":"10.3390\/cells11172710"},{"key":"1784_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"1784_CR42","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis, A. O. et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775\u20133789 (2008).","journal-title":"J. Clin. Invest."},{"key":"1784_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.06.008","volume":"11","author":"DW Jeong","year":"2024","unstructured":"Jeong, D. W. et al. SUV39H1-driven NFATc1 methylation is essential for the c-Cbl-mediated degradation of NFATc1 in an osteoclast lineage. Genes Dis. 11, 101034 (2024).","journal-title":"Genes Dis."},{"key":"1784_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/BJ20110062","volume":"436","author":"JH Kim","year":"2011","unstructured":"Kim, J. H. et al. RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation. Biochem J. 436, 253\u2013262 (2011).","journal-title":"Biochem J."},{"key":"1784_CR45","doi-asserted-by":"publisher","unstructured":"Tian, Z. et al. Targeting neddylation as a novel approach to lung cancer treatment (review). Int. J. Oncol. https:\/\/doi.org\/10.3892\/ijo.2023.5513 (2023).","DOI":"10.3892\/ijo.2023.5513"},{"key":"1784_CR46","doi-asserted-by":"publisher","first-page":"21640","DOI":"10.1074\/jbc.M513034200","volume":"281","author":"S Oved","year":"2006","unstructured":"Oved, S. et al. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J. Biol. Chem. 281, 21640\u201321651 (2006).","journal-title":"J. Biol. Chem."},{"key":"1784_CR47","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/ijms20071694","volume":"20","author":"T Komori","year":"2019","unstructured":"Komori, T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int. J. Mol. Sci. 20, 1694 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1784_CR48","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1359\/jbmr.090502","volume":"24","author":"S Zhang","year":"2009","unstructured":"Zhang, S. et al. Dose-dependent effects of Runx2 on bone development. J. Bone Min. Res. 24, 1889\u20131904 (2009).","journal-title":"J. Bone Min. Res."},{"key":"1784_CR49","doi-asserted-by":"publisher","first-page":"27939","DOI":"10.1074\/jbc.M304132200","volume":"278","author":"M Zhao","year":"2003","unstructured":"Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R. & Chen, D. E3 ubiquitin ligase Smurf1 mediates core-binding factor \u03b11\/Runx2 degradation and plays a specific role in osteoblast differentiation*. J. Biol. Chem. 278, 27939\u201327944 (2003).","journal-title":"J. Biol. Chem."},{"key":"1784_CR50","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/jbmr.1938","volume":"28","author":"L Shu","year":"2013","unstructured":"Shu, L., Zhang, H., Boyce, B. F. & Xing, L. Ubiquitin E3 ligase Wwp1 negatively regulates osteoblast function by inhibiting osteoblast differentiation and migration. J. Bone Min. Res. 28, 1925\u20131935 (2013).","journal-title":"J. Bone Min. Res."},{"key":"1784_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/jbmr.2397","volume":"30","author":"KE Lim","year":"2015","unstructured":"Lim, K. E. et al. Core binding factor \u03b2 of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. J. Bone Min. Res. 30, 715\u2013722 (2015).","journal-title":"J. Bone Min. Res."},{"key":"1784_CR52","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/cr.2014.127","volume":"24","author":"HJ Kim","year":"2014","unstructured":"Kim, H. J. et al. Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation. Cell Res. 24, 1231\u20131249 (2014).","journal-title":"Cell Res."},{"key":"1784_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm3919","volume":"16","author":"RI Enchev","year":"2015","unstructured":"Enchev, R. I., Schulman, B. A. & Peter, M. Protein neddylation: beyond cullin-RING ligases. Nat. Rev. Mol. Cell Biol. 16, 30\u201344 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1784_CR54","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/1947601910382776","volume":"1","author":"D Wei","year":"2010","unstructured":"Wei, D. & Sun, Y. Small RING finger proteins RBX1 and RBX2 of SCF E3 ubiquitin ligases: the role in cancer and as cancer targets. Genes Cancer 1, 700\u2013707 (2010).","journal-title":"Genes Cancer"},{"key":"1784_CR55","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1111\/febs.15584","volume":"288","author":"T Zou","year":"2021","unstructured":"Zou, T. & Zhang, J. Diverse and pivotal roles of neddylation in metabolism and immunity. FEBS J. 288, 3884\u20133912 (2021).","journal-title":"FEBS J."},{"key":"1784_CR56","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1038\/s41388-018-0354-5","volume":"37","author":"GW Lee","year":"2018","unstructured":"Lee, G. W. et al. The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src. Oncogene 37, 5552\u20135568 (2018).","journal-title":"Oncogene"},{"key":"1784_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41419-020-2472-6","volume":"11","author":"U-I Ju","year":"2020","unstructured":"Ju, U.-I. et al. Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment. Cell Death Dis. 11, 283 (2020).","journal-title":"Cell Death Dis."},{"key":"1784_CR58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10637-016-0348-5","volume":"34","author":"S Bhatia","year":"2016","unstructured":"Bhatia, S. et al. A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924\/MLN4924) in patients with metastatic melanoma. Investig. New Drugs 34, 439\u2013449 (2016).","journal-title":"Investig. New Drugs"},{"key":"1784_CR59","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1078-0432.CCR-15-1338","volume":"22","author":"J Sarantopoulos","year":"2016","unstructured":"Sarantopoulos, J. et al. Phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924\/MLN4924) in patients with advanced solid tumors. Clin. Cancer Res. 22, 847\u2013857 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1784_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.1","volume":"7","author":"RT Swords","year":"2017","unstructured":"Swords, R. T. et al. Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes. Blood Cancer J. 7, e520 (2017).","journal-title":"Blood Cancer J."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01784-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01784-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:14:34Z","timestamp":1788336874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01784-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01784-2","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Seoul National University (approval Nos SNU-211201-5-1, SNU-220611-1-1, SNU-220620-3, and SNU-240701-7). Human sample collection was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 2408-085-1560), and written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}